Unplanned vaccine Hualan blood products when prices are high in on the layout more development potential in the field of vaccines,Michael Kors outlet, strategic vision can be described as lofty, but not to enter areas of the company 's plan to pay for the vaccine within the government, but the market, to avoid the policy of price risk. Company after the outbreak of the influenza flu vaccine rapidly developed and expanded production capacity, reflecting the flexible and efficient private mechanisms. A flow of events affecting the company and not just short-term performance of the outbreak, but the company accelerated the development of the vaccine business is expected to quickly become one of the foreign domestic vaccine market leading enterprise planning, at present, in addition to the flu vaccine, ACYW135 meningococcal polysaccharide vaccine production approval was obtained in July, recombinant hepatitis B vaccine is expected to be achieved before the end of production numbers.
NYSE-listed Sinovac Biotech ( code AMEX: SVA),Michael Kors bags, since the flu outbreak to August 31, shares rose 393 percent, while Hualan rose 68% over the same period. coach purses Hualan can get the number of orders at home and abroad ? Hualan possible to obtain 15-20 % of the domestic backlog. Export market is very broad, but approved difficult. Hualan Although last year before entering the country in the field of vaccine, but when flu vaccine sales have held up quite well. 2008 flu vaccine batch release accounted for 13 % of the total, in the domestic market after Sanofi Pasteur.
Michael Kors handbags Estimated Westlands able to get about 15-20 % of the backlog, as reserves 65 million, that is to get 9.75 million ~ 13 million orders. Chick with the company's current supply capacity, processing and purification packaging capacity, fully able to meet orders. If, according to Hualan supply 13 million, the price of 20 yuan / agent, the gross profit margin of 60% is estimated to provide vaccine -income countries Hualan reserves amounted to 260 million yuan, gross 1. H1N1 influenza vaccine there is a huge supply gap.
Topics related articles：
没有评论:
发表评论